Analgesics
|
|
Anesthetics
|
|
Anti-Addiction / Substance Abuse Treatment Agents
|
|
Antibacterials
|
|
Anticonvulsants
|
Calcium Channel Modifying Agents
|
Gamma-aminobutyric Acid (GABA) Augmenting Agents
|
Glutamate Reducing Agents
|
Sodium Channel Agents
|
Carbamazepine
|
Ethotoin
|
Fosphenytoin
|
Lacosamide
|
Oxcarbazepine
|
Phenytoin
|
D00512 Phenytoin (JP16/USP/INN)
D02103 Phenytoin sodium for injection (JP16); Phenytoin sodium (USP)
|
Rufinamide
|
Anticonvulsants, Other
|
|
Antidementia Agents
|
|
Antidepressants
|
|
Antiemetics
|
|
Antifungals
|
|
Antigout Agents
|
|
Anti-inflammatory Agents
|
|
Antimigraine Agents
|
|
Antimyasthenic Agents
|
|
Antimycobacterials
|
|
Antineoplastics
|
|
Antiparasitics
|
|
Antiparkinson Agents
|
|
Antipsychotics
|
|
Antispasticity Agents
|
|
Antivirals
|
|
Anxiolytics
|
|
Bipolar Agents
|
|
Blood Glucose Regulators
|
|
Blood Products / Modifiers / Volume Expanders
|
|
Cardiovascular Agents
|
|
Central Nervous System Agents
|
|
Dental and Oral Agents
|
|
Dermatological Agents
|
|
Enzyme Replacement / Modifying Agents
|
|
Gastrointestinal Agents
|
|
Genitourinary Agents
|
|
Hormonal Agents
|
|
Immunological Agents
|
|
Inflammatory Bowel Disease Agents
|
|
Metabolic Bone Disease Agents
|
|
Ophthalmic Agents
|
|
Otic Agents
|
|
Respiratory Tract Agents
|
|
Skeletal Muscle Relaxants
|
|
Sleep Disorder Agents
|
|
Therapeutic Nutrients / Minerals / Electrolytes
|